MIGLUSTAT
Generic: MIGLUSTAT
Navinta LLCManufacturer
ORALRoute
MIGLUSTATActive Substance
2025-03-14Original Approval
MIGLUSTAT is FDA application ANDA219111, sponsored by NAVINTA LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
SEIZURE
22 reports
2
DIARRHOEA
19 reports
3
PNEUMONIA
18 reports
4
PYREXIA
10 reports
5
VOMITING
10 reports
6
PNEUMONIA ASPIRATION
9 reports
7
DYSPHAGIA
8 reports
8
RESPIRATORY FAILURE
8 reports
9
CONDITION AGGRAVATED
7 reports
10
COUGH
7 reports